摘要
目的:分析探讨氩氦冷冻治疗对前列腺癌患者外周血CD4+CD25+调节性T细胞(Treg)的影响及临床意义。方法:前列腺癌患者40例,分别于氩氦冷冻治疗术前、术后3个月、6个月采取外周血。放射免疫法检测外周血PSA,流式细胞仪检测外周血T淋巴细胞亚群(CD3+T、CD4+T、CD8+T、CD4+T,CD8+T、NK细胞、Treg细胞)变化情况。结果:前列腺癌患者冷冻后外周血PSA较冷冻前明显下降(P<0.01)。与治疗前比较。治疗后3个月、6个月CD3+T、CD4+T、CD4+T/CD8+T、NK细胞比例明显增高,CD8+T细胞比例降低(P<0.05),Treg细胞比例较治疗前降低(P<0.05)。冷冻后6月与冷冻后3月比较,Treg细胞无明显变化(P>0.05)。相关性分析结果表明:经氩氦冷冻治疗后Treg细胞比例变化与PSA下降呈正相关(r=0.76,P<0.01)。结论:前列腺癌氩氦冷冻治疗后外周血T淋巴细胞亚群分布异常得到一定改善,Treg细胞比例变化与肿瘤负荷大小有关。
Objective: To analyze the effect of Argon-Helium cryosurgery (AHCS) on the differentiation of regulatory CD4+ CD25+ T cell (Treg) and its implication in patients with prostate carcinoma. Methods: Peripheral venous blood samples were obtained from 40 patients with prostate cancer before AHCS and at 3 months and 6 months after AHCS. PSA in the peripheral blood was measured by radioimmunotherapy. The percentage of Treg cells and T lymphocyte subsets (CD3+ T, CD4+ T, CD8+ T, CD4+ T/CD8+ T, and NK cells) in the peripheral blood was measured by flow cytometry. Results: After AHCS, PSA level in the peripheral blood was decreased significantly (P〈0.01). After AHCS, the percentages of Treg cells were decreased (P〈 0.01). At 3 months and 6 months after AHCS, the percentages of Treg cells were steady (P〉0.05), the percentages of CD3+ T, CD4+ T, NK and CD4+ T/CD8+ T were significantly increased after AHCS (P〈0.01), and the percentage of CD8+ T cells was significantly decreased after AHCS (P〈0.01). Correlation analysis showed that the decrease of PSA was positively correlated with the decrease of the percentage of Treg cells (r=0.76, P〈0.01). Conclusion: After AHCS, the abnormal distribution of subsets of T-lymphocytes can be improved. The percentage of Treg cells is correlated with tumor load.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2009年第8期227-229,共3页
Chinese Journal of Clinical Oncology
基金
天津市自然科学基金资助(编号:09JCYBJC10400)